“Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models”. The Review of Diabetic Studies , Sept. 2025, pp. 1-21, https://doi.org/10.1900/q356v768.